Headlines

MedPro to Participate in APIC 2011 Annual Educational Conference


Company to Conduct Survey Designed to Gain User Feedback on Safety Syringes

Lexington, KY – June 14, 2011 – MedPro Safety Products, Inc. (OTCBB: MPSP), a leading developer of transformational technologies that enable safer medication delivery and blood collection, today announced that it will have a booth at the APIC Annual Educational Conference to be held in Baltimore, MD from June 27 to 29, 2011.  As part of its participation, the Company will be conducting an online survey to gain user feedback on current needle safety procedures at the MedPro Safety Booth #546.

“The APIC Conference represents an outstanding opportunity to reach out to our target market to better understand the current practices and needs of our users in enhancing safety around the use of needles,” said Bethany Denning, Director of Corporate Relations for MedPro Safety Products.  “The survey focuses on product information, essential and desirable features of safety devices, and the current state of safety syringe use in the market.  The results will enable us to refine our future product offerings as we continue to develop new passive safety medical delivery and blood collection systems for the market.”

The survey is designed to be short, about five minutes, and it is conveniently accessible from iPads at the Company’s booth.  As an added incentive, participants will be entered to win an iPad2 in the Company’s daily giveaway.

About MedPro Safety Products, Inc.

Headquartered in Lexington, Kentucky, MedPro Safety Products, Inc. is a leading developer of safer medication delivery and blood collection systems.  The Company licenses, develops and manufactures transformational technologies marketed through its global medical device partners.  MedPro’s portfolio addresses multiple product categories within the medical delivery (injection and infusion) and blood collection (blood collection sets and blood tube holders) markets.  These products incorporate needlestick prevention features considered to be the most passive now available on the market as they require little or no clinician training compared to competitive products.  The total global market opportunity currently addressed by the Company’s products is estimated to be in excess of $6 billion.  For additional information, please refer to the ‘Investor Relations’ link on MedPro’s website (http://www.medprosafety.com).

Contact Information:

Investor Contact:

Doug Sherk/Jenifer Kirtland

EVC Group

415-896-6820

Media Contact:

Steve DiMattia

EVC Group

646-201-5445